Drugs with abnormal price changes will be subject to production cost investigation

[industry trends of pharmaceutical network] recently, Sichuan Provincial Pharmaceutical Machinery bidding and purchasing service center issued the notice on the investigation of the production cost of drugs with abnormal price changes, which refers to those drugs with frequent price increases, large price differences between regions and large price differences between the same kind of drugs According to the notice, in order to grasp the situation of drug production cost, analyze the reasons for the abnormal change of drug price, scientifically and reasonably respond to the abnormal change of drug price, and guide the reasonable formation of drug price, Sichuan Province will make specific work arrangements for the investigation of drug production cost of the abnormal change of price implemented from now on According to the notice, the cost investigation will cover four types of drugs First, drugs with abnormal price changes required by the State Medical Security Bureau to carry out production cost investigation; second, drugs with abnormal price rise or frequency and large price difference between regions; fourth, drugs with excessive price difference of the same product, significantly higher price increase in circulation links and insufficient competition Product For these four types of drugs, the difference between domestic and imported ones is different Among them, the content of domestic drug production cost investigation includes drug production cost and related production, operation, finance, product flow and price The investigation of import cost of imported drugs includes import cost, related operation, finance, product flow and price, etc The author understands that in recent years, the phenomenon of frequent price increase of some drugs has attracted much attention On December 6, 2019, "opinions on the current drug price management" was released, in which specific explanations were made on drug price, circulation, sales and other aspects Generally speaking, it is necessary to control the drug price within a reasonable range and manage at all levels, so as not to make mistakes in any link The circular also shows that the investigation of drug production cost is mainly in written form, and field investigation will be adopted when necessary For the field investigation of pharmaceutical manufacturers and importers in Sichuan Province, the provincial pharmaceutical machinery bidding and purchasing service center will conduct field investigation to the enterprises For enterprises in other provinces, it is necessary to provide the center with a field investigation report on the cost of drug production recognized by the local provincial medical security department For those drugs with abnormal price increase or frequency, large price difference between regions, large price difference of the same variety, obvious price increase in circulation link beyond the reasonable level and insufficient competition, relevant testing departments will analyze and investigate according to the drug price monitoring results and take reasonable countermeasures At the same time, enterprises that want to increase the price of drug on the Internet will face more stringent investigation When submitting the application materials of drug on the Internet, they need to submit the production cost information of the drug together, which will be an important basis for analyzing the rationality of the price increase The industry believes that the work of drug cost audit in Sichuan Province is just the beginning, after which more provinces should start drug cost audit and carry out unified verification In general, with the tightening of drug price supervision and the promotion of the second round of belt purchase, drug companies will face a serious blow in drug price On the basis of compliant production and operation, in the future, pharmaceutical enterprises will either reduce prices or gradually reduce the corresponding market mode of transformation, and the reshuffle of the pharmaceutical industry has begun.